TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15121485
Abstract: Kidney fibrosis is a common pathophysiological mechanism of chronic kidney disease (CKD) progression caused by several underlying kidney diseases. Among various contributors to kidney fibrosis, transforming growth factor-β1 (TGF-β1) is the major factor driving fibrosis.… read more here.
Keywords: kidney fibrosis; tgf inhibitors; kidney; management ... See more keywords